Welcome to LookChem.com Sign In|Join Free

CAS

  • or

943994-74-9

Post Buying Request

943994-74-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

943994-74-9 Usage

Description

Methyl 2-(4-bromo-2-methyl-6-nitrophenoxy)acetate is a chemical compound with the molecular formula C11H12BrNO5. It is a yellow crystalline solid that is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. This phenoxyacetic acid derivative contains a phenoxy group and an acetate group, with the presence of bromo and nitro substituents on the phenyl ring, making it a versatile building block for the construction of various complex molecules.

Uses

Used in Pharmaceutical Synthesis:
Methyl 2-(4-bromo-2-methyl-6-nitrophenoxy)acetate is used as an intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into complex molecular structures, contributing to the development of new drugs.
Used in Agrochemical Synthesis:
It is also used as an intermediate in the synthesis of agrochemicals, particularly due to its structural similarity to known compounds used in agriculture, such as pesticides or herbicides.
Used in Organic Synthesis:
Methyl 2-(4-bromo-2-methyl-6-nitrophenoxy)acetate is utilized as a versatile building block in organic synthesis, allowing for the creation of a wide range of complex molecules for various applications across different industries.

Check Digit Verification of cas no

The CAS Registry Mumber 943994-74-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,9,9 and 4 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 943994-74:
(8*9)+(7*4)+(6*3)+(5*9)+(4*9)+(3*4)+(2*7)+(1*4)=229
229 % 10 = 9
So 943994-74-9 is a valid CAS Registry Number.

943994-74-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-(4-bromo-2-methyl-6-nitrophenoxy)acetate

1.2 Other means of identification

Product number -
Other names FD7269

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:943994-74-9 SDS

943994-74-9Relevant articles and documents

Discovery of 6-[5-(4-fluorophenyl)-3-methyl-pyrazol-4-yl]-benzoxazin-3-one derivatives as novel selective nonsteroidal mineralocorticoid receptor antagonists

Hasui, Tomoaki,Ohyabu, Norio,Ohra, Taiichi,Fuji, Koji,Sugimoto, Takahiro,Fujimoto, Jun,Asano, Kouhei,Oosawa, Masato,Shiotani, Sachiko,Nishigaki, Nobuhiro,Kusumoto, Keiji,Matsui, Hideki,Mizukami, Atsushi,Habuka, Noriyuki,Sogabe, Satoshi,Endo, Satoshi,Ono, Midori,Siedem, Christopher S.,Tang, Tony P.,Gauthier, Cassandra,De Meese, Lisa A.,Boyd, Steven A.,Fukumoto, Shoji

, p. 5428 - 5445 (2014/12/10)

In the course of our study on selective nonsteroidal mineralocorticoid receptor (MR) antagonists, a series of novel benzoxazine derivatives possessing an azole ring as the core scaffold was designed for the purpose of attenuating the partial agonistic activity of the previously reported dihydropyrrol-2-one derivatives. Screening of alternative azole rings identified 1,3-dimethyl pyrazole 6a as a lead compound with reduced partial agonistic activity. Subsequent replacement of the 1-methyl group of the pyrazole ring with larger lipophilic side chains or polar side chains targeting Arg817 and Gln776 increased MR binding activity while maintaining the agonistic response at the lower level. Among these compounds, 6-[1-(2,2-difluoro-3-hydroxypropyl)-5-(4-fluorophenyl)-3-methyl-1H-pyrazol-4-yl]-2H-1,4-benzoxazin-3(4H)-one (37a) showed highly potent in vitro activity, high selectivity versus other steroid hormone receptors, and good pharmacokinetic profiles. Oral administration of 37a in deoxycorticosterone acetate-salt hypertensive rats showed a significant blood pressure-lowering effect with no signs of antiandrogenic effects.

FUSED HETEROCYCLIC COMPOUND AND USE THEREOF

-

Page/Page column 351-352, (2008/06/13)

The present invention relates to wherein each symbol is as defined in the specification. The compound has a superior mineral corticoidreceptorantagonistic action and is useful as an agent for the prophylaxis or treatment of hypertension, cardiac failure and the like, a compound having a fused heterocycle, or a prodrug thereof, or a salt thereof; and an agent for the prophylaxis or treatment of hypertension, cardiac failure and the like.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 943994-74-9